Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAD2L1 |
| Upstream (Parents) |
|---|
| (<<) CCNB2 → MAD2L1 |
| Downstream (Children) |
|---|
| MAD2L1 → STIL (>>) |
| MAD2L1 → HMGB2 (>>) |
| MAD2L1 → SUV39H2 (>>) |
| MAD2L1 → FAM64A (>>) |
| MAD2L1 → GAL (>>) |
| MAD2L1 → SLC7A11 (>>) |
| MAD2L1 → PBK (>>) |
| MAD2L1 → KIF11 (>>) |
| MAD2L1 → CD3EAP (>>) |
| MAD2L1 → FBXO5 (>>) |
| MAD2L1 → GTSE1 (>>) |
| MAD2L1 → MST4 (>>) |
